Who owns Synta Pharmaceuticals?

Key details on Synta Pharmaceuticals (Ticker: SNTA)

Who owns Synta Pharmaceuticals?

Is SNTA a good stock to own? Find out who bought Synta Pharmaceuticals, who sold Synta Pharmaceuticals (SNTA) stock, and who holds a large position in Synta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
CAXTON 28.64M $123.44M March 31, 2014
Jennison Associates 6.62M $11.52M Sept. 30, 2015
BlackRock Fund Advisors 4.31M $7.50M Sept. 30, 2015
Vanguard 4.29M $1.50M Dec. 31, 2015
FMR 3.73M $6.48M Sept. 30, 2015
Jefferies 3.24M $6.29M March 31, 2015
Perceptive Advisors 2.38M $15.03M Sept. 30, 2013
S.A.C. Capital Advisors 2.01M $12.66M Sept. 30, 2013
ARMISTICE CAPITAL 2.00M $3.48M Sept. 30, 2015
JPMORGAN CHASE & CO 1.76M $9.22M Dec. 31, 2013
QVT Financial 1.75M $11.04M Sept. 30, 2013
Sectoral Asset Management 1.48M $11.30M Sept. 30, 2012
Baker Bros. Advisors 1.40M $6.98M June 30, 2013
Barclays 1.28M $6.38M June 30, 2013
SUSQUEHANNA INTERNATIONAL 1.14M $3.43M Sept. 30, 2014
NORTHERN TRUST 1.02M $1.76M Sept. 30, 2015
STATE STREET CORPORATION 941271 $1.64M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 912428 $1.59M Sept. 30, 2015
Ayer Capital Management 851635 $3.70M March 31, 2012
Manatuck Hill Partners 784116 $6.74M March 31, 2013
Ironwood Investment Management 738748 $1.43M March 31, 2015
GOLDMAN SACHS 731321 $3.15M March 31, 2014
Geode Capital Management 717826 $1.25M Sept. 30, 2015
Millennium Management 717510 $1.90M Dec. 31, 2014
Driehaus Capital Management 713498 $6.14M March 31, 2013
D. E. Shaw & Co 687566 $2.07M Sept. 30, 2014
Renaissance Technologies 656700 $1.27M March 31, 2015
Deutsche Bank Aktiengesellschaft 652298 $3.42M Dec. 31, 2013
MORGAN STANLEY 630445 $1.67M Dec. 31, 2014
Hambrecht & Quist Capital Management 625000 $3.42M June 30, 2012
Oxford Asset Management 601896 $3.80M Sept. 30, 2013